Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:59 PM
9.54
-0.41%
After-hours: Aug 15, 2025, 04:11 PM EDT
1.59%
Bid 9.54
Market Cap 1.56B
Revenue (ttm) 1.08B
Net Income (ttm) 422.82M
EPS (ttm) 2.22
PE Ratio (ttm) 4.32
Forward PE -418.25
Analyst Hold
Ask 9.56
Volume 6,621,196
Avg. Volume (20D) 7,869,062
Open 9.49
Previous Close 9.43
Day's Range 9.27 - 9.89
52-Week Range 5.01 - 15.22
Beta 2.50

About NVAX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVAX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Novavax has released their quartely earnings on Aug 6, 2025:
  • Revenue of $239.24M exceeds estimates by $93.03M, with -42.42% YoY decline.
  • EPS of 0.62 exceeds estimates by 0.74, with -37.37% YoY decline.
  • Next Earnings Release

    Novavax Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +12.63%
    Novavax shares are trading higher after the compan... Unlock content with Pro Subscription
    2 months ago
    -0.78%
    Shares of vaccine stocks are trading higher following a report indicating FDA advisers will consider if COVID-19 vaccines should target the LP.8.1 subvariant for 2025-2026.